Management of Urticarioid Reaction after MPRV Vaccine in a 6-Year-Old Child

Introduction to Urticarioid Reactions

The American Academy of Pediatrics recommends that a urticarioid reaction after MPRV vaccine is generally mild, self-limiting, and not an absolute contraindication to subsequent doses, but requires an allergological evaluation before revaccination to rule out allergy to specific vaccine components such as gelatin or neomycin 1, 2

The Centers for Disease Control and Prevention (CDC) states that mild urticarioid reactions (localized urticaria, pruritus) are common and occur in about 2-3% of children after MMRV vaccination 3, 4, 5
The timing of the reaction can suggest an IgE-mediated allergy if immediate (within minutes to hours), while late reactions (5-12 days) are typically correlated with the viral immune response 4, 6
Systemic symptoms associated with the reaction, such as angioedema, respiratory distress, wheezing, hypotension, or shock, indicate anaphylaxis 1, 7

For isolated urticaria without systemic symptoms, observation for 15-20 minutes and oral antihistamines if necessary are recommended 7
Signs of anaphylaxis (generalized urticaria, oropharyngeal edema, wheezing, respiratory distress, hypotension) require immediate action, including positioning the child supine with legs elevated and administering oxygen if necessary 7

The CDC recommends determining the allergic cause of the reaction, as reactions to MPRV vaccines are rarely caused by the viral antigens themselves but more frequently by residual components like gelatin, neomycin, or egg proteins 1, 8
Gelatin is the stabilizer in MMR/MMRV vaccines and the most common cause of anaphylactic reactions 1, 8
Neomycin is present in traces; contact allergy (delayed dermatitis) is not a contraindication, only previous anaphylaxis 1
Egg proteins are not correlated with anaphylactic reactions, as the vaccines are grown in chicken embryo fibroblasts 1, 8

If the reaction was localized or mild, the child can receive subsequent doses of MMRV without special precautions 3, 4, 5
Local reactions (erythema, swelling, rash at the injection site) are more frequent with MMRV (2.3%) compared to separate vaccines and do not contraindicate subsequent doses 4, 5, 9
No allergological testing is necessary for mild and local reactions 1, 8

History of anaphylactic reaction to neomycin 2
Allergic reaction to gelatin, other vaccine components, or after previous MMRV/MMR/varicella vaccination 2

At 6 years, the child has likely received the second dose of MMRV (recommended at 4-6 years) 10, 2
Adverse reactions are generally less frequent after the second dose compared to the first 4, 5, 9
If this was the first dose (late vaccination), the risk of fever and febrile seizures is lower compared to younger children, as 97% of febrile seizures occur before 47 months 10, 2

Do not confuse delayed contact dermatitis to neomycin with IgE-mediated allergy: only the latter is a contraindication 1
Do not automatically attribute the reaction to egg proteins: measles/mumps vaccines can be administered to children with severe egg allergy 1, 8
Do not unnecessarily delay vaccination for mild reactions: localized urticaria is not a contraindication 3, 4, 5

Report clinically significant adverse events to the national pharmacovigilance system 10, 2
Accurately document the nature, timing, and severity of the reaction in the vaccination record 7
Inform parents about signs of anaphylaxis and the need for post-vaccination observation 10, 2